Dividends Calendar Earnings Calendar
SNDX

SNDX | Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Waltham, Massachusetts, United States

Trade prices

  • Volume:
  • Market Cap: 913.8M
  • Prev closed:
  • Open: 17.84
  • High: 18.46
  • Low: 17.18
  • 52 week low: 13.02
  • 52 week high: 27.12
  • Dividends:No Dividends

Next ER: May 9, 2022  After Market Closes



Top Stories (SNDX)

    Company Profile

    Syndax Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Through our pipeline agents, entinostat, a late stage, class 1 specific HDAC inhibitor and SNDX-6352, a phase 1 anti-CSF-1R monoclonal antibody, we are determined to realize a future in which people with cancer live longer and better than ever before. Syndax corporate headquarters are in Waltham, MA.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    August 11, 2022
    May 9, 2022-0.63 / -0.6343.25M / 2.17MBeat!
    March 1, 20221.81 / -0.5866126.58M / 6.29MBeat!
    November 15, 2021-0.4 / -0.162812.38M / 29.41M
    August 9, 2021-0.44 / -0.7145379K / 225KBeat!
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    May 9, 2022 15.11 15.67
    16.12
    14.74
    950.11K -6.03%
    May 6, 2022 16.08 16.31
    16.45
    15.94
    594.83K -3.19%
    May 5, 2022 16.61 17.31
    17.41
    16.23
    445.24K -5.14%
    May 4, 2022 17.51 17.14
    17.62
    16.36
    825.53K 1.45%
    May 3, 2022 17.26 17.31
    17.43
    16.96
    238.91K 0.41%
    May 2, 2022 17.19 16.60
    17.26
    16.41
    416.04K 2.50%
    Apr 29, 2022 16.77 16.75
    17.45
    16.70
    585.89K -0.89%
    Apr 28, 2022 16.92 16.50
    17.04
    15.84
    676.49K 3.49%
    Apr 27, 2022 16.35 16.30
    16.58
    16.08
    280.69K 0.31%
    Apr 26, 2022 16.30 16.52
    16.78
    15.86
    622.99K -2.63%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2005
    • Employees:43

    News

    News for (SNDX)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  W. Morrison
    • CFO :  Daphne Karydas
    • Treasurer :  Daphne Karydas
    • Chief Medical Officer :  Michael L. Meyers

    Talk about Syndax Pharmaceuticals Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on May 9, 2022 (Same day)

    znga tsn coty spg su enr duk exc acm jll iii meg 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 75
    HOLD 25
    SELL 0

    Their Official Profiles 

    TwitterLinkedIn

    Peers / Similar stocks 

    xlv 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Swing Trading For Dummies
    Buy on Amazon

    Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.

    Take advantage of price swings in strongly trending securities and pump up your portfolio!